Insider Trading April 13, 2026 04:14 PM

Datadog CEO Executes $4.7M Sale of Class A Shares; Firm Posts Product and Analyst Updates

Olivier Pomel sold multiple tranches under a 10b5-1 plan while converting Class B shares and exercising options on April 9, 2026

By Nina Shah DDOG
Datadog CEO Executes $4.7M Sale of Class A Shares; Firm Posts Product and Analyst Updates
DDOG

Datadog Chief Executive Olivier Pomel sold $4.7 million of Class A common stock on April 9, 2026 under a pre-arranged 10b5-1 plan, converting Class B shares into Class A and exercising stock options the same day. The share sales occurred amid recent price weakness and follow product launches and analyst coverage that highlight the company's exposure to AI-driven demand and observability markets.

Key Points

  • CEO Olivier Pomel sold $4.7 million of Datadog Class A shares on April 9, 2026 under a 10b5-1 plan, across multiple transactions priced between $109.0601 and $118.2386.
  • Pomel converted 42,443 Class B shares into Class A shares and exercised options to purchase 73,833 Class B shares at exercise prices of $0.9092 and $10.74.
  • Product and analyst developments emphasize Datadog’s exposure to AI-driven observability and security trends, with recent analyst ratings including Guggenheim (Buy, $175 PT) and Stifel (Buy, $160 PT).

Insider transactions

Datadog, Inc. (NASDAQ: DDOG) reported that Chief Executive Officer Olivier Pomel sold a total of $4.7 million of Class A common stock on April 9, 2026. The share disposals were carried out under a pre-established 10b5-1 trading arrangement and took place across multiple transactions with execution prices spanning from $109.0601 to $118.2386 per share.

The company’s Form 4 filing with the Securities and Exchange Commission records the tranches as follows:

  • 14,743 shares at a weighted average price of $109.0601
  • 5,700 shares at $110.0381
  • 7,295 shares at $111.0256
  • 4,606 shares at $111.8834
  • 4,100 shares at $113.0967
  • 2,699 shares at $113.8647
  • 500 shares at $115.017
  • 1,000 shares at $116.2342
  • 1,100 shares at $117.4451
  • 700 shares at $118.2386

Also disclosed on April 9, 2026, Pomel converted 42,443 shares of Class B common stock into Class A common stock. The filing further notes the exercise of stock options to acquire 73,833 shares of Class B common stock at exercise prices of $0.9092 and $10.74.


Market backdrop and valuation signal

The transactions occurred against a backdrop of downward price movement for Datadog shares, which have fallen 9.6% over the last week and 35.8% over the past six months, according to InvestingPro data. Despite that recent weakness, InvestingPro analysis referenced in the filing indicates the stock is currently viewed as undervalued relative to its Fair Value assessment.


Product developments and analyst views

Separately, Datadog announced the general availability of its MCP Server, a tool that provides developers with live observability data intended for integration with AI agents. The company describes the product as enabling real-time telemetry for debugging AI coding agents and Integrated Development Environments while maintaining security and governance controls.

On the sell-side, Guggenheim upgraded Datadog to a Buy rating and assigned a $175.00 price target, citing the company’s positioning in AI-driven growth. Guggenheim analyst Howard Ma highlighted the firm’s backend architecture and leadership in agentic observability. Stifel also reiterated a Buy rating with a $160 price target, noting Datadog’s two-pronged approach to capturing AI-related spending through embedded AI capabilities in its products and solutions aimed at securing the AI stack.

Wells Fargo provided a constructive view in its preview of first-quarter results for the U.S. software sector, underscoring investor selectivity and a focus on defensiveness related to artificial intelligence exposure. RBC Capital commented on Anthropic’s Project Glasswing, describing it as supportive for companies involved in securing critical software, naming CrowdStrike and Palo Alto Networks in that context.


What the filings and coverage show

The Form 4 disclosures make three elements clear: the CEO sold specified tranches of Class A shares under a 10b5-1 plan; a conversion of Class B shares into Class A occurred the same day; and option exercises were executed to obtain additional Class B shares at stated exercise prices. Those corporate actions coincided with product rollout news and several analyst moves that emphasize Datadog’s ties to AI-enabled observability and security markets.

Investors reviewing the filings and related commentary will find both near-term price weakness and analyst support reflected in the public record. The filings themselves document the exact share counts, prices, conversion amounts, and option exercise details without offering commentary on motivations beyond the mechanics of the transactions.


Note: The article presents the information disclosed in regulatory filings and public analyst commentary without inferring motives or projecting outcomes beyond the reported facts.

Risks

  • Recent share price weakness - Datadog shares have declined 9.6% over the past week and 35.8% over the last six months, which may affect investor sentiment in the software sector.
  • Insider selling may be perceived negatively by market participants despite the trades occurring under a pre-arranged 10b5-1 plan, potentially influencing short-term equity liquidity and price dynamics.
  • Investor selectivity in the U.S. software sector and emphasis on AI defensiveness could create uncertainty for companies competing for AI-related spending, affecting demand and valuation comparatives.

More from Insider Trading

Hippo CEO Disposes of $130,250 in Stock; Company Signals Ongoing Operational Momentum Apr 13, 2026 Liquidia CEO Executes $1.00M Share Sale as Company Advances Yutrepia Launch Apr 13, 2026 Westwood Holdings Director Emerita Disposes $47K in Company Shares Apr 13, 2026 Workday Insider Sells $12 Million in Stock Amid Mixed Signals from Analysts and Results Apr 13, 2026 RA Capital Increases Stake in Adicet Bio with $1.6M Purchase Apr 13, 2026